Biohit Oyj
HLSE:BIOBV
1.99
-0.02€ (-1.00%)
1.99
-0.02€ (-1.00%)
End-of-day quote: 05/02/2024

Biohit Oyj financials at a glance

The revenue of Biohit Oyj is reported as 0.0131 billion Euro in the fiscal year 2023. The earnings were 0.12 Euro per share in 2023, which was 200 higher than 2007. And about -0.0002 billion Euro are reported as free cash flow in the financials of Biohit Oyj 2023. No dividends were paid to the shareholders of the Biohit Oyj stock HLSE:BIOBV in the financial year 2023.

13.10€M
Revenue
0.12€
Earnings Per Share
63.36%
Gross Margin %
0.80€M
Free Cash Flow
Revenue
13.10
Earnings Per Share
0.12
Gross Margin %
63.36
Free Cash Flow
0.80

Financials

Year Year TTM 2023 2007 2006 2005 2004
Rev. Revenue N/A 13.10€M 32.75€M 31.40€M 28.70€M 26.70€M
GM % Gross Margin % 63.54% 63.36% 79.71% 79.54% 80.17% 79.11%
OM Operating Margin 9.94% 12.21% -0.99% -0.64% -0.14% 0.91%
EPS Earnings Per Share 0.07€ 0.12€ -0.12€ -0.06€ -0.02€ -0.05€
Div. Dividends N/A 0.00€ 0.00€ 0.00€ 0.00€ 0.00€
PR % Payout Ratio % 0 0.00% -0.00% -0.00% -0.00% -0.00%
Sha. Shares N/AM 15.11M 12.94M 12.94M 12.94M 12.94M
OCF Operating Cash Flow N/A 1.60€M 1.04€M 0.00€M 0.00€M 0.00€M
FCF Free Cash Flow N/A 0.80€M -1.02€M 0.00€M 0.00€M 0.00€M
FCFS Free Cash Flow Per Share 0.02€ 0.05€ -0.08€ -0.12€ -0.07€ 0.01€